arrow
M

Marco Merli

niguarda hospital
H指数:22
被引数:1,707

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Antibiotic Strategies for Multidrug-Resistant Pseudomonas aeruginosa: Evidence from the Italian SUSANA Multicentre Study

针对多重耐药铜绿假单胞菌的现实世界抗生素策略:来自意大利SUSANA多中心研究的证据

2026-08-270
OA
Community-acquired pneumonia outside the intensive care unit: Clinical characteristics and impact of rapid molecular diagnostics in the Italian SIS-NET study

非重症监护病房社区获得性肺炎:意大利SIS-NET研究的临床特征和快速分子诊断的影响

2026-07-170
OAAI
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST Study

一项随机临床试验比较莫西沙星与阿奇霉素治疗生殖支原体的效果:FARTHEST研究

2026-05-170
PRE
Targeted Peri-operative Prophylaxis in Patients Colonized With Carbapenem Resistant Enterobacterales Undergoing Liver Transplantation: A Multinational Cohort Study

对携带碳青霉烯耐药肠杆菌科细菌并接受肝移植手术患者进行围手术期靶向预防:一项跨国队列研究

2026-04-010
PRE
Use of a molecular syndromic panel for the etiological diagnosis of bloodstream infections in critically ill patients: impact on clinical outcomes and antimicrobial use from a multicenter, prospective study

利用分子综合征面板对危重患者血流感染进行病因学诊断:一项多中心、前瞻性研究对临床结局和抗菌药物使用的影响

2026-01-010
OAAI
Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern Italy

厄他培南/他唑巴坦与碳青霉烯类治疗产超广谱β-内酰胺酶肠杆菌科细菌血流感染的疗效比较:一项在意大利北部急诊科进行的倾向性评分匹配观察性研究

2025-12-150
PRE
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

HIV感染者与非感染者肝细胞癌诊断后的5年生存率比较:一项多中心研究

2025-11-181
OAAI
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study

使用分子综合征检测板进行呼吸机相关细菌性肺炎的病因学诊断:一项多中心、前瞻性研究对临床结局和抗生素使用的影响

2025-10-030
OAAI
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study

Giacobbe, D.R.; Bartalucci, C.; Bavastro, M. ICU危重患者中使用伊沙康唑的前瞻性、观察性、多中心、队列研究。JAC Antimicrob. Resist. 2025, 7, dlaf177. [Google Scholar] [CrossRef]

2025-10-010
PRE
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

免疫抑制患者中双重抗病毒疗法的效果与耐受性

2025-08-240
PRE
Treatment and Follow-up of Vascular Graft and Endograft Infection: Delphi Consensus Document

血管移植物和腔内移植物感染的诊治与随访:德尔菲共识文件

2025-07-290
OAAI
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections

铜绿假单胞菌血流感染中30天死亡的风险因素及经验性治疗的作用

2025-07-280
PRE
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

长期SARS-CoV-2感染的免疫抑制患者双重抗病毒治疗的有效性和耐受性

2025-02-260
OAAI
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study

适当的经验性联合治疗对铜绿假单胞菌血流感染所致脓毒症休克死亡率的影响: 一项多中心回顾性队列研究

2024-09-033
PRE